Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of 102.31 million. The enterprise value is 56.81 million.
| Market Cap | 102.31M |
| Enterprise Value | 56.81M |
Important Dates
The next estimated earnings date is Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
| Current Share Class | 979.95M |
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.96% |
| Owned by Institutions (%) | 0.11% |
| Float | 949.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.98 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.52 |
| EV / Sales | 1.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.42 |
Financial Position
The company has a current ratio of 7.01, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.01 |
| Quick Ratio | 6.11 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.56% and return on invested capital (ROIC) is -12.45%.
| Return on Equity (ROE) | -18.56% |
| Return on Assets (ROA) | -11.67% |
| Return on Invested Capital (ROIC) | -12.45% |
| Return on Capital Employed (ROCE) | -21.87% |
| Weighted Average Cost of Capital (WACC) | 11.40% |
| Revenue Per Employee | 243,468 |
| Profits Per Employee | -160,163 |
| Employee Count | 141 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.06 |
Taxes
| Income Tax | -182,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +118.09% in the last 52 weeks. The beta is 1.34, so Zomedica's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +118.09% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 46.64 |
| Average Volume (20 Days) | 849,438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, Zomedica had revenue of 34.33 million and -22.58 million in losses. Loss per share was -0.02.
| Revenue | 34.33M |
| Gross Profit | 22.76M |
| Operating Income | -24.71M |
| Pretax Income | -22.77M |
| Net Income | -22.58M |
| EBITDA | -17.08M |
| EBIT | -24.71M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 47.51 million in cash and 2.01 million in debt, with a net cash position of 45.50 million or 0.05 per share.
| Cash & Cash Equivalents | 47.51M |
| Total Debt | 2.01M |
| Net Cash | 45.50M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 110.95M |
| Book Value Per Share | 0.11 |
| Working Capital | 51.47M |
Cash Flow
In the last 12 months, operating cash flow was -16.26 million and capital expenditures -347,000, giving a free cash flow of -16.61 million.
| Operating Cash Flow | -16.26M |
| Capital Expenditures | -347,000 |
| Depreciation & Amortization | 7.63M |
| Net Borrowing | n/a |
| Free Cash Flow | -16.61M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 66.29%, with operating and profit margins of -71.97% and -65.78%.
| Gross Margin | 66.29% |
| Operating Margin | -71.97% |
| Pretax Margin | -66.31% |
| Profit Margin | -65.78% |
| EBITDA Margin | -49.75% |
| EBIT Margin | -71.97% |
| FCF Margin | n/a |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -22.07% |
| FCF Yield | -16.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zomedica has an Altman Z-Score of 1.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 2 |